Hub genes identified here (IL1R2, FOS, MMP9, DUSP1, and CLEC4D) represent a whole blood gene signature of anaphylaxis with STEMI predisposition and provide candidate diagnostic and therapeutic targets for follow-up studies. The gene discussed is FOS; the disease is anaphylaxis.